MGMT testing—the challenges for biomarker-based glioma treatment-Reference-Cited by-同舟云学术

MGMT testing—the challenges for biomarker-based glioma treatment

Published:2014-06-10 Issue:7 Volume:10 Page:372-385
ISSN:1759-4758
Container-title:Nature Reviews Neurology
language:en
Short-container-title:Nat Rev Neurol

Author:

Wick Wolfgang,Weller Michael,van den Bent Martin,Sanson Marc,Weiler Markus,von Deimling Andreas,Plass Christoph,Hegi Monika,Platten Michael,Reifenberger Guido

Publisher

Springer Science and Business Media LLC

Subject

Cellular and Molecular Neuroscience,Neurology (clinical)

Link

http://www.nature.com/articles/nrneurol.2014.100.pdf

Reference106 articles.

1. Hess, K. R., Broglio, K. R. & Bondy, M. L. Adult glioma incidence trends in the United States, 1977–2000. Cancer 101, 2293–2299 (2004).

2. Wen, P. Y. & Kesari, S. Malignant gliomas in adults. N. Engl. J. Med. 359, 492–507 (2008).

3. Hegi, M. E. et al. MGMT gene silencing and benefit from temozolomide in glioblastoma. N. Engl. J. Med. 352, 997–1003 (2005).

4. Weller, M. et al. Molecular predictors of progression-free and overall survival in patients with newly diagnosed glioblastoma: a prospective translational study of the German Glioma Network. J. Clin. Oncol. 27, 5743–5750 (2009).

5. Friedman, H. S. et al. Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma. J. Clin. Oncol. 27, 4733–4740 (2009).

Cited by 450 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunosuppressive MDSC and Treg signatures predict prognosis and therapeutic response in glioma;International Immunopharmacology;2024-11

2. Radiogenomic profiling of global DNA methylation associated with molecular phenotypes and immune features in glioma;BMC Medicine;2024-09-02

3. Two decades of progress in glioma methylation research: the rise of temozolomide resistance and immunotherapy insights;Frontiers in Neuroscience;2024-09-02

4. Genomic Landscape of Pancreatic Neuroendocrine Tumors and Implications for Clinical Practice;JCO Precision Oncology;2024-09

5. Increased UBD Is a Potential Diagnostic and Prognostic Biomarker in Glioma;Environmental Toxicology;2024-08-18